More bad news for Mylan Pharmaceuticals and the 3.6 million Americans who depend on the life-saving antidote to anaphylactic allergic reactions. Last summer, we explored the obscenely high cost of purchasing automatic epinephrine dispensers, also known as EpiPens, and the very bad public relations fallout that followed news of a 400% price increase over a decade. We explained how EpiPens work:
With the EpiPen, the medicine is premeasured. There is no alcohol swab. In fact, a doctor doesn’t even need to be present; most older kids and adults can self-administer the medicine by themselves. They jab the pen directly into the thigh — even through clothing! — and the needle in the device instantaneously extends to deliver the dose of epinephrine before immediately retracting back into the device. No stress, no mess.
If you receive Pediatric Alliance’s newsfeed on Facebook (and you should! – it includes your daily PediaBlog fix), then you already know that there has been a recall of certain lots of EpiPen and EpiPen Jr. Autoinjectors. The problem is a “potential defect [that] could make the device difficult to activate in an emergency (failure to activate or increased force needed to activate) and have significant health consequences for a patient experiencing a life-threatening allergic reaction (anaphylaxis).”
You can find more details on this product recall (generic EpiPens are not included in the recalled lots), lot numbers, and how to return recalled EpiPens here.
Comments are closed.